Indirubin-3’-monoxime acts as proteasome inhibitor: Therapeutic application in multiple myeloma
2022 · EBioMedicine · 32 citations
https://doi.org/10.1016/j.ebiom.2022.103950
F
Fancui Meng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
78
Papers
719
Citations
16
h-index
25
i10-index
Fancui Meng is an academic researcher from Tianjin Institute of Pharmaceutical Research (China). The author has contributed to research in topics: DNA and Nucleic Acid Chemistry & Lipid Membrane Structure and Behavior & Crystallography and molecular interactions. The author has an h-index of 16, co-authored 67 publications.
ORCID: 0000-0002-5064-0618Papers by this author
worksCharacterization of the ligand binding of PGRP-L in half-smooth tongue sole ( Cynoglossus semilaevis ) by molecular dynamics and free energy calculation
2017 · Electronic Journal of Biotechnology · 4 citations
https://doi.org/10.1016/j.ejbt.2017.10.010
Structural insights into ligand binding of PGRP1 splice variants in Chinese giant salamander (Andrias davidianus) from molecular dynamics and free energy calculations
2017 · Journal of Molecular Modeling · 3 citations
https://doi.org/10.1007/s00894-017-3315-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat